You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康泰醫學(300869.SZ):TP500醫用紅外體温計通過美國FDA審核
格隆匯 12-23 16:40

格隆匯 12 月 23日丨康泰醫學(300869.SZ)公佈,近日,公司收到美國食品藥品監督管理局U.S. Food and Drug Administration(“FDA”)批准函,公司TP500醫用紅外體温計(Infrared Thermometer)已通過FDA的510(K)審核,510(K)號碼:K201980。

TP500醫用紅外體温計通過FDA審核後,可以對公司美國市場現有產品形成有效補充。產品上市後實際銷售情況取決於未來市場的推廣效果,目前尚無法預測上述產品對公司未來營業收入的影響,敬請廣大投資者謹慎投資,注意防範投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account